Table 1 Summary of smoke exposure experiments for validation in this study.
Experiments | Cigarette type | Sample code | Tar (mg/cig) | Nicotine (mg/cig) | Dilution times | Sampling time (hour) after exposure |
|---|---|---|---|---|---|---|
Optimal concentration | Reference | 3R4F | 9.4 | 0.73 | 1/10, 1/30, 1/100, 1/300,1/500,1/1000 | 0 |
Transcriptomic profiling: reference versus commercial cigarette | Reference | 3R4F_0 | 9.4 | 0.73 | 1/500 | 0 |
Reference | 3R4F_4 | 9.4 | 0.73 | 1/500 | 4 | |
Reference | 3R4F_24 | 9.4 | 0.73 | 1/500 | 24 | |
Commercial | CB8_0 | 8 | 0.8 | 1/500 | 0 | |
Commercial | CB8_4 | 8 | 0.8 | 1/500 | 4 | |
Commercial | CB8_24 | 8 | 0.8 | 1/500 | 24 | |
Transcriptomic profiling: different tar/nicotine contents | Commercial | AB8_4 | 8 | 0.7 | 1/500 | 4 |
Commercial | AB12_4 | 12 | 1 | 1/500 | 4 | |
Commercial | CB8_4 | 8 | 0.8 | 1/500 | 4 |